| Literature DB >> 28070268 |
Amy L Minkalis1, Robert D Vining1, Cynthia R Long1, Cheryl Hawk2, Katie de Luca3.
Abstract
PURPOSE: Although many conservative management options are available for patients with non-surgical shoulder conditions, there is little evidence of their effectiveness. This review investigated one manual therapy approach, thrust manipulation, as a treatment option.Entities:
Keywords: Chiropractic; Manual therapy; Non-surgical; Shoulder; Shoulder impingement syndrome; Spinal manipulation; Thrust manipulation
Year: 2017 PMID: 28070268 PMCID: PMC5215137 DOI: 10.1186/s12998-016-0133-8
Source DB: PubMed Journal: Chiropr Man Therap ISSN: 2045-709X
Article eligibility criteria
| Inclusion | Exclusion |
|---|---|
| • Human participants of any age | • Any treatment other than thrust manipulation |
aShoulder conditions were defined as those involving the proximal humerus, clavicle, scapula, sternoclavicular, glenohumeral, and acromioclavicular joints
Fig. 1Search results and screening
Descriptive characteristics of the included studies assessing treatments for subacromial impingement syndrome
| Author & Year | Study Design | Participantsa | Diagnosis | Treatment Frequency | Data collection | Intervention | Comparison | Outcome Measures | Results |
|---|---|---|---|---|---|---|---|---|---|
| Kardouni et al. 2015 [ | RCT |
| 3 of 5 positive signs or in-office exam findings | 1 treatment | Pre, post & 24–48 h post-treatment | Active thoracic SMT; prone lower, mid- and seated upper thoracic treatment (x2) for a total of 6 SMT maneuvers | Sham thoracic SMT with identical positioning | NPRSc
| Pre-post mean change: active group, −0.9; sham group, −1.2; main effect within group ( |
| Kardouni et al. 2015 [ | RCT |
| 5 of 7 positive signs or in-office exam findings | 1 treatment | Pre, post & 24–48 h post-treatment | Active thoracic SMT; prone lower, mid- and seated upper thoracic treatment (x2) for a total of 6 SMT maneuvers | Sham thoracic SMT with identical positioning | NPRSe
| Pre-post mean change: active group, −0.9; sham group, −1.5; main effect within group ( |
| Haik et al. 2014 [ | RCT |
| 3 of 7 positive signs or in-office exam findings | 1 treatment | Pre and Post | Active thoracic SMT; seated mid-thoracic manipulation | Sham thoracic SMT | NPRSg
| Pre-post mean change: active group, −0.8; sham group, −0.2; main effect within group ( |
| Munday et al. 2007 [ | RCT |
| 3 of 4 positive signs or in-office exam findings | 8 treatments in 3 weeks | Baseline (1st visit), 3 weeks (8th treatment) & 1-month follow-up | Group B ( | Group A ( | VASh
| Pre-post mean change within groups: group A, −29.17 ( |
| Boyles et al. 2009 [ | Non-randomized study |
| ≥2 NPRS plus + Neer or Hawkins-Kennedy and ≥2 NPRS on active shoulder abduction or on resisted test (internal or external rotation; empty can) | 1 treatment | Pre and Post | Thoracic SMT; seated mid-thoracic and cervicothoracic junction; supine rib manipulation (if required) | N/A | NPRSi
| Pre-post mean change: Neer, −1.1 ( |
| Muth et al. 2012 [ | Non-randomized study |
| ≥3 NPRS on performance of Hawkins-Kennedy, Neer, or Jobe tests | 1 treatment | Pre, post & 7–10 days post-treatment | Thoracic SMT; seated mid-thoracic (focus on apex of the thoracic kyphosis) and cervicothoracic junction | N/A | NPRSj (0–10) | Pre-post mean change: Jobe, −2.6 ( |
RCT randomized controlled trial, SMT thrust spinal manipulative therapy, NPRS numeric pain rating scale, PSS Penn shoulder score, VAS visual analog scale, SFMPQ short-form McGill pain questionnaire, EC empty can, IR internal rotation, ER external rotation, ABD abduction, SPADI shoulder pain and disability index, CI confidence interval, ROM range of motion, EMG electromyo-graphy
aMean age ± SD
bA higher score is better
cSecondary outcome assessed at baseline, immediately post-treatment, and at 24–48 h follow-up; primary outcome was thoracic motion
dSecondary outcome assessed at baseline and at 24–48 h follow-up; primary outcome was thoracic motion
eSecondary outcome assessed at baseline, immediately post-treatment, and at 24–48 h follow-up; primary outcome was pain pressure threshold
fSecondary outcome assessed at baseline and at 24–48 h follow-up; primary outcome was pain pressure threshold
gPrimary outcome assessed pre- and immediately post-treatment; another primary outcome was scapular kinematics
hPrimary outcome assessed at baseline, week 3 and at 1-month follow-up; another primary outcome was pain pressure threshold
iPrimary outcome assessed at baseline and at 48-h follow-up; secondary outcome was Global Rating of Change Scale
jSecondary outcome assessed at baseline and immediately post-treatment; other secondary outcomes included force production and ROM; primary outcomes were scapular kinematics and EMG
kSecondary outcome assessed at 7–10 days follow-up; result mean change ± SD; other secondary outcomes included force production and ROM; primary outcomes were scapular kinematics and EMG
Articles excluded at full-text review
| Author | Reason for exclusion |
|---|---|
| Atkinson [ | Intervention not described |
| Bang [ | Multi-modal treatment |
| Bialoszewski [ | No thrust manipulation |
| Buchbinder [ | No thrust manipulation |
| Coombes [ | Intervention not described |
| Coronado [ | No diagnosis or not applicable |
| Crowell [ | No thrust manipulation |
| Desjardins [ | Systematic review |
| Dunning [ | No diagnosis or not applicable |
| Foster [ | No thrust manipulation |
| Ha [ | No thrust manipulation |
| Harris [ | No thrust manipulation |
| Howe [ | Outcome not clinical or applicable |
| Jewell [ | No thrust manipulation |
| Johnson [ | Multi-modal treatment |
| Kazemi [ | Multi-modal treatment |
| Kukkonen [ | No thrust manipulation |
| Kukkonen [ | No thrust manipulation |
| Michener [ | Outcome not clinical or applicable |
| Negahban [ | Multi-modal treatment |
| Pribicevic [ | Multi-modal treatment |
| Rhon [ | No thrust manipulation |
| Riley [ | Multi-modal treatment |
| Riley [ | Multi-modal treatment |
| Senbursa [ | No thrust manipulation |
| Vermeulen [ | No thrust manipulation |
| Wassinger [ | No diagnosis or not applicable |
| Winters [ | Multi-modal treatment |
| Yang [ | No thrust manipulation |
| Yilmaz [ | No thrust manipulation |
PEDro scale criteria and scoringa
| Criterion | Study | |||
|---|---|---|---|---|
| Munday 2007 [ | Haik 2014 [ | Kardouni 2015 [ | Kardouni 2015 [ | |
| Random allocation | ✔ | ✔ | ✔ | ✔ |
| Concealed allocation | ✔ | ✔ | ||
| Baseline comparability | ✔ | ✔ | ✔ | ✔ |
| Subject blinding | ✔ | ✔ | ||
| Therapist blinding | ||||
| Assessor blinding | ✔ | ✔ | ✔ | |
| Follow-up | ✔ | ✔ | ✔ | |
| Intention-to-treat | ||||
| Between group analysis | ✔ | ✔ | ✔ | ✔ |
| Point estimates and variability | ✔ | ✔ | ✔ | ✔ |
| Total | 4/10 | 6/10 | 8/10 | 8/10 |
aRanking as follows: 9 to 10 is considered excellent, 6 to 8 is good, 4 to 5 is fair, and 3 or
below represents poor quality
Detailed risk-of-bias assessment using the Cochrane toola
| Munday 2007 [ | Boyles 2009 [ | Muth 2012 [ | Haik 2014 [ | Kardouni 2015 [ | Kardouni 2015 [ | |
|---|---|---|---|---|---|---|
| Random sequence generation (selection bias) | + | − | − | + | + | + |
| Allocation concealment (selection bias) | + | − | − | + | + | + |
| Blinding of participants (performance bias) | − | − | − | − | + | + |
| Blinding of provider (performance bias) | − | − | − | − | − | − |
| Blinding of outcome assessment—PROs (detection bias) | − | − | − | ? | ? | ? |
| Incomplete outcome data addressed—short-term (attrition bias) | − | ? | ? | ? | ? | ? |
| Selective reporting (reporting bias) | ? | − | − | − | ? | ? |
| Other potential bias | + | + | + | + | + | + |
| TOTAL | 7/16 | 3/16 | 3/16 | 8/16 | 11/16 | 11/16 |
aLow risk (+); unclear risk (?); high risk (−)